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An inverse relationship between birth weight and coronary artery diseases is well documented but it remains unclear which
exposure in early life might underlie such association. Recently it has been reported an association between adenosine deaminase
genetic polymorphism and coronary artery diseases. Gender diﬀerences in the degree of this association have been also observed.
T h e s eo b s e r v a t i o n sp r o m p t e du st os t u d yt h ep o s s i b l ej o i n te ﬀects of BW, ADA, and gender on the susceptibility to coronary
artery diseases. 222 subjects admitted to hospital for nonfatal coronary artery diseases, and 762 healthy consecutive newborns
were studied. ADA genotypes were determined by DNA analysis. A highly signiﬁcant complex relationship has emerged among
ADA, birth weight, and gender concerning their role on susceptibility to coronary artery diseases in adult life. Odds ratio analysis
suggests that low birth weight is more important in females than in males. ADA∗2 allele appears protective in males, while in
females such eﬀect is obscured by birth weight.
Copyright © 2009 F. Gloria-Bottini et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Recently an association between Adenosine Deaminase
(ADA) genetic polymorphism and Coronary Artery Disease
(CAD) has been reported [1]; subjects carrying the ADA∗2
allele are less represented among CAD patients than in
controls. We have conﬁrmed in males this association [2].
An inverse relationship between birth weigh (BW) and CAD
is well documented, and we have conﬁrmed this association
in females [3]. Since it remains unclear which exposure in
early life might underlie the relationship between BW and
CAD [4], in the present note we have reanalyzed our data to
searchforpossibleinteractionsamongBW,ADA,andgender
concerning susceptibility to CAD.
1.1. Adenosine Deaminase Genetic Polymorphism. ADA is a
polymorphic enzyme present in all mammalian tissues [5].
It is controlled by a locus with 2 codominant alleles ADA∗1
and ADA∗2 located on the long arm of chromosome 20 [6].
ADA catalyses the irreversible deamination of adenosine to
inosine.Redbloodcells(RBCs)areinequilibriumwithfreely
diﬀusing adenosine [7] pointing to animportant role forthis
enzyme in the regulation of adenosine concentration.
Adenosine is an important local hormone regulating
blood ﬂow, neurotransmission, physiology of smooth mus-
cle, and platelet aggregation. In the liver adenosine counter-
acts insulin action by activating A2B receptors [8].
ADA and CD26 are colocalized on T-cell surface, but
not inside cells. Cells expressing ADA and CD26 on the
surface are much more resistant to the inhibitory eﬀects of
adenosine.
Through the regulation of glucose metabolism, genetic
variation of adenosine concentration due to ADA poly-
morphism may have an important role in intrauterine
development and bilirubin metabolism in the newborn.2 Cardiology Research and Practice
Table 1: Correlation between variables in subjects with CAD and
in newborn infants from the same population.
CAD Healthy newborns
Correlation Coeﬃcient Signiﬁcance
(P)
Coeﬃcient Signiﬁcance
(P)
Gender-ADA −0.159 .016 0.087 .092
ADA-BW −0.165 .066 −0.038 .461
Gender-BW 0.351 .000 0.002 .971
Severe ADA deﬁciency is a systemic metabolism disorder
associated to organ dysfunction [9]. The possible metabolic
and clinical eﬀects of the common ADA∗2 variant that is
associated with a 15% reduction of enzymatic activity have
not received much attention in the medical literature but it is
likely that it could be responsible for variation of metabolic
and clinical parameters.
2.MaterialandMethods
222 subjects admitted consecutively to the Hospital for non
fatal CAD were studied. 762 consecutive newborn infants
were considered as controls. All subjects were Italians from
the White population of Central Italy.
ADAphenotype/genotypewasdeterminedbyDNAanal-
ysis in CAD subjects [10] and by starch gel electrophoresis
[5] in newborns. In our laboratory no diﬀerence has been
observed between the two methods. Moreover in the popu-
lation of the Central Italy we have observed the same distri-
bution of ADA genotypes (phenotypes) by the two methods.
Reliable information on Birth Weight was obtained in
126 subjects with CAD.
Chi-square test of independence, correlation analysis,
and principal component analysis were carried out by SPSS
package[11].PrincipalComponentAnalysisgivesasynthesis
of the overall pattern of correlations among variables. Start-
ing from a correlation matrix, the method extracts indepen-
dent components giving the contribute of original variables
to each component. A component showing an Eigenvalue
greater than 1 is considered signiﬁcant. Three-way contin-
gency table analysis was carried out by a log-linear model
according to Sokal and Rohlf [12]. Clinical data in subjects
with CAD have been reported in a previous paper [3].
3. Results
Table 1 shows the pattern of the correlations among BW,
ADA, and gender. The correlation between ADA and gender
in CAD patients is opposite to that in healthy newborns.
The correlation between gender and BW is highly signiﬁcant
in CAD only and the correlation between ADA and BW is
border line in CAD and is absent in newborns.
Table 2 shows the results of Principal Component Analy-
sis performed on BW, ADA, and gender. There are important
diﬀerence in all parameters considered between CAD and
newborns suggesting a peculiar pattern of correlation among
BW, ADA, and gender in CAD. This is particularly evident
consideringthecontributionofthethreevariablestotheﬁrst
component.
In the following tables the pattern of correlations among
the three variables has been analyzed in details.
Table 3 shows the distribution of ADA phenotypes in
healthy newborns and in CAD patients. In males, the
proportion of carriers of ADA∗2 allele is signiﬁcantly lower
in CAD than in controls. In females the diﬀerence is
not statistically signiﬁcant. A three way contingency table
analysis by a log-linear model suggests that the association
of ADA with CAD depends on gender.
Table 4 showstherelationshipbetweenBWandgenderin
healthy newborns and in CAD patients. We have considered
twoclasses:BW ≤3000g(correspondingtotheﬁrstquartile)
and BW > 3000g. In CAD the proportion of subjects with a
BW ≤ 3000g is much greater in females than in males. This
is not observed among healthy newborns.
Table 5 shows the distribution of ADA phenotypes
in relation to gender in healthy newborns and in CAD
separately for subjects with a BW ≤ 3000g and for those
withaBW>3000g.TheinteractionamongADAphenotype,
gender, and disease observed in Table 3 is statistically signif-
icant in subjects with a low BW only suggesting a complex
interaction among ADA, gender, and BW concerning their
eﬀects on susceptibility to CAD.
Table 6 shows the distribution of BW in relation to ADA
and gender in healthy newborns and in CAD. In CAD, ADA
and BW contribute signiﬁcantly to diﬀerentiate males from
females. No signiﬁcant eﬀect of these variables is observed in
healthy newborns.
In Table 7 we have summarized the complex relationship
between ADA, BW, gender and susceptibility to CAD. A
highlysigniﬁcant interaction is observed. Infemalesthejoint
ADA-BW phenotype distribution shows a highly signiﬁcant
diﬀerence between CAD and newborns while in males no
signiﬁcant association is observed. Concerning susceptibility
to CAD Odds ratio analysis suggests that low BW is more
important in females than in males. ADA∗2a l l e l ea p p e a r s
protective in males, while in females such eﬀect is obscured
by the eﬀect of BW.
4. Discussion
Correlation analysis shows that the pattern of correlations
among BW, gender, and ADA in subject with CAD is
signiﬁcantly diﬀerent from that observed in healthy subjects.
ADA∗2 allele is less represented in CAD males as compared
to females but such diﬀerence is evident in subjects with a
relatively low birth weight only. On the other hand a direct
association between BW, and CAD is observed in females
only. Moreover CAD females carrying the ADA∗2a l l e l e
shows a lower BW compared to ADA∗1/∗1f e m a l e sb u ts u c h
association is not observed in males. Overall, this indicates
a complex interaction involving gender, BW and ADA
concerning their eﬀects on susceptibility to CAD. Statistical
analysis suggests that in males prevails the eﬀect of ADA
polymorphism, while in females prevails the eﬀect of BW.Cardiology Research and Practice 3
Table 2: Principal component analysis.
CAD Healthy newborns
Communalities
Sex 0.598 0.449
BW 0.552 0.110
ADA 0.338 0.537
Eigenvalue %variance Eigenvalue %variance
Total variance explained
1◦ component 1.487 49.56% 1.096 36.53%
2◦ component 0.861 28.70% 0.997 33.22%
3◦ component 0.652 21.74% 0.908 30.25%
1rst component 1rst component
Component matrix
Sex 0.773 0.670
BW 0.743 −0.331
ADA −0.581 0.733
Table 3: Distribution of ADA phenotypes in healthy newborns and in subjects with CAD.
Healthy newborns CAD
Chi square test of independence
χ2 df P
Females
%o fc a r r i e r so fA D A ∗2 allele 15.7% 18.3% 0.3606 1 .620
total no. 368 104
Males
%o fc a r r i e r so fA D A ∗2 allele 15.5% 7.6% 4.637 1 .035
total no. 394 118
Three-way contingency table analysis by a log-linear model:
x = samples (healthy newborn versus CAD) y = ADA, and z = gender.
x y z interaction: G df P
4.382 1 .042
The lower activity of ADA∗2a l l e l ec o m p a r e dt oA D A ∗1
results in higher concentration of adenosine that in turn may
exert a positive role on cardiac function. This may represent
a possible explanation of the negative association between
ADA∗2 allele and CAD. Indeed ecto-ADA interacts with
Adenosine Receptors A1 that inﬂuences ischemic precon-
ditioning [13–16]. Moreover adenosine inﬂuences platelet
aggregation [16] and has important immunomodulatory
property [17].
The developmental origin of adult diseases theory pos-
tulates that foetal undernutrition increases the susceptibility
to coronary artery disease and allied disorders in later
stages of life [18]. The inverse association observed between
BW and CAD supports this hypothesis. Gender diﬀerence
in the pattern of association between BW and CAD has
been also reported [4]. However it remains to discover the
factors acting in early life that might be responsible for
the association between development and susceptibility to
an important class of adult diseases [4]. Studies on adults
exposed to maternal undernutrition have not demonstrated
anassociationwithCAD[19]suggestingthatotherunknown
factors, probably also genetic, could have an important role
in the link between development and susceptibility to CAD
in adult life.
In this context based on the association of ADA poly-
morphism with peculiar neonatal events we have proposed
another line of investigation [20].
We have shown that ADA genetic variability inﬂuences
neonatal bilirubin levels. In particular ADA∗2a l l e l ei sm o r e
represent in newborns with high serum bilirubin level as
compared to newborns with low level [21, 22]. On the other
hand several studies indicate a beneﬁcial action of bilirubin
in the neonatal period due to its protective eﬀects from
secondary oxidant formed in the oxidative process [23–25].
We have observed that the proportion of carriers of
ADA∗2 allele in newborns who have undergone photother-
apy for high bilirubin level during the ﬁrst few days of life
is higher as compared to those who have not undergone
such treatment [21, 22]. On the other hand the proportion
of carriers of ADA∗2 allele is lower in CAD than in
healthysubjects[1].Thepatternissuggestive;theassociation
between ADA and CAD might have origin from peculiar
events occurring in early stages of extra uterine life.
Since the newborn is particularly susceptible to oxidative
damage, the eﬀect of ADA∗2 allele on bilirubin level could
result in a protection against oxidative damage and in turn
in long-term positive eﬀect on the protection towards CAD
in adult life. Hormonal diversity could be responsible for4 Cardiology Research and Practice
Table 4: Birth weight in relation to gender in healthy newborns and in subjects with CAD.
Healthy newborns CAD Chi square test of independence
2χ df P
Females
% proportion of newborns with a BW ≤ 3000g∗ 25.8% 59.3% 26.677 1 <10−6
total no. 368 59
Males
% proportion of newborns with a BW ≤ 3000g∗ 22.1% 25.4% 0.105 1 .745
total no. 394 67
∗3000g corresponds to the ﬁrst quartile.
Table 5: Distribution of ADA phenotypes in relation to gender and birth weight in healthy newborns and in subjects with CAD.
BW ≤ 3000g Healthy newborns CAD
Females
%o fc a r r i e r so fA D A ∗2 allele 13.7% 28.6%
total no. 95 35
Males
%o fc a r r i e r so fA D A ∗2 allele 17.2% 5.9%
total no. 87 17
Three-way contingency table analysis by a log-linear model
x = samples (healthy newborn vs CAD), y = ADA, and z = gender
x y z interaction G df P
4.495 1 .037
BW > 3000g
Females
%o fc a r r i e r so fA D A ∗2 allele 16.5% 12.5%
total no. 273 23
Males
%o fc a r r i e r so fA D A ∗2 allele 15.0% 8.0%
total no. 307 50
Three-way contingency table analysis by a log-linear model
x = samples, y = ADA, and z = gender
x y z interaction G df P
0.205 1 .680
Table 6 :B i r t hw e i g h ti nr e l a t i o nt oA D Ap h e n o t y p ei nh e a l t h yn e w b o r na n di ns u b j e c t sw i t hC A D .
Healthy newborns CAD
ADA 1/1 Carriers of ADA∗2 allele ADA 1/1 Carriers of ADA∗2a l l e l e
Females
% proportion of newborns with a BW ≤ 3000g 26.5% 22.4% 54.3% 76.9%
total no. 310 58 46 13
Males
% proportion of newborns with a BW ≤ 3000g 21.6% 24.6% 25.8% 20.0%
total no. 333 61 62 5
Three-way contingency table analysis by a log-linear model
x = ADA, y = BW, and z = gender
x y z interaction G df P Gd f P
0,674 1 .430 1.121 1 .320
Independence of factor z from factors x and y 2.145 3 .380 19.732 3 .0002Cardiology Research and Practice 5
Table 7: The relationship among joint ADA-BW phenotype, gender, and sample (CAD versus newborn).
CAD Newborns
Females Males Females Males
ADA1/1 BW ≤ 3000g (A) 42.2% 23.9% 22.3% 18.3%
Joint ADA-BW phenotype ADA1/1 BW > 3000g (B) 35.6% 68.7% 62.0% 66.2%
ADA∗2 carrier BW ≤ 3000g (C) 16.9% 1.5% 3.5% 3.8%
ADA∗2 carrier BW > 3000g (D) 5.1% 6.0% 12.2% 11.7%
total no. 59 67 368 394
Three-way contingency table analysis by a log-linear model
x = gender, y = joint ADA-BW phenotype, and z = sample (CAD versus newborns)
x y z interaction G df P
13.605 3 .005
Chi-square test of independence (CAD versus newborns)
χ2 df P
Female/ 33.551 3 <10−6
Males 3.595 3 .308
Odds ratio analysis (CAD versus newborns)
Joint ADA-BW phenotype
A versus others B versus others C versus others D versus others
Females OR 2.564 0.339 5.573 0.384
95% CI 1.392–4.716 0.183–0.623 2.130–14.487 0.099–1.346
Males OR 1.403 1.116 0.382 0.480
95% CI 0.721–2.701 0.619–2.024 0.016–2.83 0.141–1.457
gender diﬀerences. These diﬀerences, however, could be the
expression of diﬀerent clinical severity leading to diﬀerent
rates of mortality between sexes. Indeed our cases include
nonfatal CAD only, and we have no information on fatal
cases.
5. Study Limitations
The present observations should be conﬁrmed in another
clinical setting before drawing deﬁnitive conclusion. An
important limitation is due to lack of case fatality rate that
might be diﬀerent between sexes inﬂuencing the degree of
correlations observed in our cases.
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